Apex Part 1: Updated Assessment of Bezuclastinib (CGT9486), a Selective KIT D816V Tyrosine Kinase Inhibitor, in Patients with Advanced Systemic Mastocytosis (AdvSM)
Authors
Daniel DeAngelo,
Jason GotlibVinod Pullarkat,
Pankit Vachhani,
Tsewang Tashi,
Stephanie Lee,
Gary Schiller,
Anthony Hunter,
Miguel Piris‐Villaespesa,
Helena Pomares,
Bulai Cridtina,
Khalid Shoumariyeh,
Jonathan Lambert,
Tracy George,
Jay Patel,
Cristina Papayannidis,
Tania Jain,
Michael Deininger,
Andreas Reiter,
Gabriela Hobbs,
Lei Sun,
Deepak Nagendra,
Jenna Zhang,
Amanda Pilla,
Kim Dishman,
Marcus Carden +24 authors
,
Deepti Radia
Tip
Tip